Chinook Tyee Industry Ltd Stock Toronto S.E.
Equities
GBI.H
CA16961T2083
Pharmaceuticals
Sales 2021 | 453K 329K | Sales 2022 | - | Capitalization | 3.43M 2.49M |
---|---|---|---|---|---|
Net income 2021 | -3M -2.18M | Net income 2022 | -1M -726K | EV / Sales 2021 | 24.5 x |
Net Debt 2021 | 1.87M 1.36M | Net Debt 2022 | 3.15M 2.29M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.14
x | P/E ratio 2022 |
-1.79
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 74.11% |
Managers | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 12-12-13 |
Director/Board Member | 72 | 18-12-04 | |
Investor Relations Contact | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 12-12-13 |
Director/Board Member | 72 | 18-12-04 | |
Frank Otto
BRD | Director/Board Member | - | 22-05-10 |
1st Jan change | Capi. | |
---|---|---|
+37.12% | 6B | |
-14.61% | 4.42B | |
-10.58% | 3.06B | |
+0.86% | 2.99B | |
-0.94% | 2.48B | |
+36.18% | 1.78B | |
-10.82% | 1.58B | |
-4.89% | 1.52B | |
-12.50% | 1.49B |